Sunday, May 10, 2026

SkySouth Aviation Expands Medical Air Transport Network Following 1,000th Organ Mission Milestone

SkySouth Aviation, a private jet charter and Fixed Base Operator (FBO) at the Burlington-Alamance Regional Airport (KBUY), announced Friday a strategic expansion of its critical medical air transport services. The move comes as the company celebrates a significant operational milestone: the completion of its 1,000th organ transport mission.

Since its inception in 2003, SkySouth has evolved from a regional charter operator into a specialized logistics partner for hospital networks, organ procurement organizations, and transplant surgery teams. This expansion aims to bolster the company’s capacity to support time-sensitive medical missions across the Southeastern United States, a region characterized by its high density of world-class research hospitals and academic medical centers.

A Critical Link in the Transplant Chain

In the field of transplant medicine, the window of viability for donor organs is exceptionally narrow. The logistics of moving a surgical team alongside a time-sensitive organ require a level of precision and reliability that commercial aviation—burdened by scheduled departures and airport security queues—cannot consistently offer.

"When transplant surgeons and medical coordinators call us, minutes matter," said Kevin Mock, founder of SkySouth Aviation. "We have spent more than two decades building the systems, the team, and the reputation that hospitals trust when lives are on the line. This expansion reflects our commitment to being available whenever and wherever a medical network needs us across the Southeast."

SkySouth’s operational model is designed to eliminate the friction typically associated with private air travel. By maintaining a 24/7 dispatch capability, the company ensures that aircraft are ready to depart as soon as a donor alert is received. This responsiveness is vital to maintaining the integrity of delicate organs, such as hearts or lungs, which must be transplanted within a strict timeframe to ensure the best possible patient outcomes.

The Fleet: Specialized Assets for Specialized Missions

Central to SkySouth’s medical operations are its Cessna Citation light jets. The company operates a fleet consisting of the Citation CJ1 and the Citation CJ3. Both aircraft are selected for their ability to operate out of smaller regional airports, which are often located closer to specialized medical hubs than the large international facilities favored by commercial airliners.

The Citation CJ3, in particular, has become the primary asset for the company’s heart transplant missions. In January, the company completed a full interior refit of the aircraft, ensuring it meets the unique environmental and spatial requirements of surgical teams. With a cruising speed of 480 miles per hour and a range of approximately 1,500 nautical miles, the CJ3 provides the necessary speed to traverse the Southeast quickly while offering sufficient cabin volume for medical teams to manage heavy equipment and maintain sterile protocols in flight.

The CJ1 complements this by providing a nimble, cost-effective solution for shorter-range missions or for transporting lab specimens and tissue, where time is of the essence but the logistical footprint may be smaller.

Strategic Geography and Operational Reach

SkySouth’s base in Burlington, N.C., is a cornerstone of its regional strategy. Positioned strategically within the Piedmont Triad and the Research Triangle, the company is within a short flight or driving distance of major medical centers in Greensboro, Raleigh, Durham, and Chapel Hill. These cities house some of the most prominent transplant programs in the United States, making the Burlington-Alamance Regional Airport an ideal staging ground for rapid response.

While the current expansion focuses heavily on the Southeast, the company’s operational reach extends far beyond North Carolina. SkySouth is equipped to facilitate medical missions throughout the continental United States, as well as into Canada, Bermuda, and the Caribbean. This geographic flexibility allows the company to serve as a vital link for patients or donor networks that require international or cross-border coordination.